David R. Holmes, Jr., MD

A Randomized Trial of the Low-Molecular-Weight Heparin Certoparin to Prevent Restenosis Following Coronary Angioplasty

08/01/2008

Ali E. Denktas , MD;

James L. Orford , MBChB, MPH, MD;

Kevin A. Bybee , MD;

David R. Holmes Jr., MD;

Panayotis Fasseas , MD;

Charanjit S. Rihal , MD, MBA, FSCAI;

Coronary angioplasty has become a successful and widely used treatment for patients with coronary artery disease since its first clinical application in 1977. However, late (36 month) restenosis rates (20–30%) continue to be the most...

Coronary angioplasty has become...

08/01/2008

Journal of Invasive Cardiology

Original Contribution

Outcomes of Radial Versus Femoral Access in Patients With Severe Aortic Stenosis Undergoing Percutaneous Coronary Intervention Prior to Transcatheter Aortic Valve Replacement

05/01/2022

Charanjit S. Rihal , MD, MBA, FSCAI;

Abdallah El Sabbagh , MD;

Mohammed A. Al-Hijji , MD;

Mackram F. Eleid , MD;

Mohammed Al-Khouli , MD;

Salman Farhat , MBBS;

Yader Sandoval , MD;

Keniel Pierre , MD;

Malcolm R. Bell , MD;

Nahyr S. Lugo-Fagundo , MD;

Rajiv Gulati , MD, PhD;

Michael S. Gharacholou , MD;

Mayra Guerrero , MD;

Peter M. Pollak , MD;

David R. Holmes Jr., MD;

Mandeep Singh Randhawa , MD;

This study included consecutive patients who underwent PCI within 30 days before TAVR at Mayo Clinic. Vascular access was left to the discretion of the operator. Baseline demographics, procedural data, PCI outcomes, and subsequent...

This study included consecutive...

05/01/2022

Journal of Invasive Cardiology

Hurry, It’s a STEMI! But How Quick is Too Quick for Safety?

07/31/2013

David R. Holmes Jr., MD;

E. Magnus Ohman , MD;

Barry F. Uretsky , MD;

Peter B. Berger , MD;

Eric Bates ;

Gregg W. Stone , MD, FACC, FSCAI;

Robert J. Applegate , MD;

Sunil V. Rao , MD, FACC, FSCAI;

Ted Feldman , MD, FSCAI, FACC, FESC;

Morton J. Kern , MD, MSCAI, FACC, FAHA;

Christopher J. White , DO, MD;

I asked my expert cath lab colleagues to weigh in on this issue with 3 quick answers on whether forced reduction of D2B time is 1) beneficial for the patient or 2) the hospital or 3) the interventionalist, and if you have time, a short...

I asked my expert cath lab...

07/31/2013

Cath Lab Digest

Feature

Refractory Angina and Anterior Ischemia in a Patient with a Patent Left Internal Mammary Artery Bypass Graft

08/01/2008

David R. Holmes Jr., MD;

Ali E. Denktas , MD;

Panayotis Fasseas , MD;

James L. Orford , MBChB, MPH, MD;

Charanjit S. Rihal , MD, MBA, FSCAI;

Kevin A. Bybee , MD;

NULL

08/01/2008

Journal of Invasive Cardiology

Feature

Refractory Angina and Anterior Ischemia in a Patient with a Patent Left Internal Mammary Artery Bypass Graft

08/01/2008

Ali E. Denktas , MD;

David R. Holmes Jr., MD;

Panayotis Fasseas , MD;

Charanjit S. Rihal , MD, MBA, FSCAI;

James L. Orford , MBChB, MPH, MD;

Kevin A. Bybee , MD;

Case Description.A 50-year-old man was referred to our institution for evaluation and management of angina pectoris. He had experienced exertional chest pain three years prior to this admission, which had initially been treated medically....

Case Description.A 50-year-old...

08/01/2008

Journal of Invasive Cardiology